Status:
RECRUITING
The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids
Lead Sponsor:
Sohag University
Conditions:
Persistent or Chronic ITP Not Respnding to Steroids
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by a low platelet count, purpura, and hemorrhagic episodes caused by antiplatelet autoantibodies. The diagnosis is typicall...
Eligibility Criteria
Inclusion
- pediatric patients with persistent or chronic Itp on thrombopoietin receptor agonists unresponsive to steroid.
Exclusion
- Any patient with other causes of thrombocytopenia. Any patient with chronic disease . Any patient with Acute ITP . Any newly diagnosed patient with ITP.
Key Trial Info
Start Date :
July 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 14 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06568913
Start Date
July 14 2024
End Date
July 14 2025
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University hospitals
Sohag, Egypt